Pilot may determine viability of long COVID management models Dr Ken McCroary on the results of tracking post-COVID sequalae in south-west Sydney, and what is needed for long-term viability of a GP-led clinic.
Does vaccination reduce long COVID risk? Research suggests illness severity and vaccination status influence the chance of patients seeking medical care in the six months post-infection.
Queries over long COVID prevalence in Australia An international review estimates that 'at least' one in 10 people with COVID-19 will develop lasting symptoms, but that may overstate the risk.
‘A constellation of symptoms’: Long COVID in focus The first public hearing into long COVID has taken place as clinicians attempt to work out the scale of the problem, and one GP reports a rising demand for treatment.
Diabetes risk could be 28% higher after COVID infection A study has noted increased type 2 diabetes incidence in people recovering from COVID, signalling the need for ongoing monitoring.
What causes long COVID? New Australian research has identified two proteins present in the body of those who report lingering symptoms post-infection.
Long COVID guidelines updated ahead of expected ‘influx’ The RACGP has updated its guidelines following concerns that people with post-COVID-19 conditions have ‘flown under the radar’.
WHO officially recognises long COVID It is hoped the clinical case definition will help doctors diagnose the condition, which affects more than one in three people infected with COVID-19.
Australian geneticist discovers new condition causing blindness The newly identified ROSAH syndrome causes blindness, splenomegaly and migraine headaches.